ASPIRA PATHLAB & DIAGNOSTICS
Back to All Ratios
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year EV/CE History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| EV/CE(x) | 6.49 | 2.82 |
What is the latest EV/CE ratio of ASPIRA PATHLAB & DIAGNOSTICS ?
| Year | EV/CE |
|---|---|
| Mar2025 | 6.49 |
| Mar2024 | 2.82 |
How is EV/CE of ASPIRA PATHLAB & DIAGNOSTICS Trending?
| Years | EV/CE | % Change | |
|---|---|---|---|
| Mar2025 | 6.49 | 130.14 | |
| Mar2024 | 2.82 | - | |
Other Financial Ratios of ASPIRA PATHLAB & DIAGNOSTICS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹124.4 Cr | 21.1% | 31.5% | 81.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,792.0 Cr | 2.8% | 2.5% | 12.2% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹103,069.0 Cr | 3.7% | 6.6% | -10.2% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹67,512.1 Cr | 2.1% | -1.5% | -10.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹65,493.1 Cr | 1.9% | -0.7% | 22.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,480.1 Cr | NA | 5.5% | 8.9% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | 21.1% |
31.5% |
81.1% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses